Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

Hierarchical Capillary Coating to Biofunctionlize Drug-Eluting Stent for Improving Endothelium Regeneration

The drug-eluting stent (DES) has become one of the most successful and important medical devices for coronary heart disease, but yet suffers from insufficient endothelial cell (EC) growth and intima repair, eventually leading to treatment failure. Although biomacromolecules such as vascular endothel...

Full description

Bibliographic Details
Main Authors:	Jing Wang, Yunfan Xue, Jun Liu, Mi Hu, He Zhang, Kefeng Ren, Yunbing Wang, Jian Ji
Format:	Article
Language:	English
Published:	American Association for the Advancement of Science (AAAS) 2020-01-01
Series:	Research
Online Access:	http://dx.doi.org/10.34133/2020/1458090

Similar Items

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
by: Josep Gomez‐Lara, et al.
Published: (2021-11-01)

MODERN COATING TECHNOLOGIES FOR DRUG ELUTING CORONARY STENTS (REVIEW)
by: E. Y. Zagorulko, et al.
Published: (2019-01-01)

Development of drug-eluting stent coated with PLGA nanoparticles as drug carriers
by: Yusuke Tsukada, et al.
Published: (2013-12-01)

Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents
by: Qing Ma, et al.
Published: (2021-12-01)

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

miR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis
by: Jing Wang, et al.
Published: (2021-12-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
by: Walid Maamoun
Published: (2013-09-01)

A modern generation of drug-eluting stents. Focusing on a sirolimus-eluting stent Calypso
by: А. Н. Кудряшов, et al.
Published: (2017-04-01)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
by: Paweł Gąsior, et al.
Published: (2018-11-01)

Long-Term Clinical Outcomes of Polymer-Free Sirolimus-Eluting Stent and Polymer-Coated Sirolimus-Eluting Stent in Patients with Type 2 Diabetes
by: Yang O, et al.
Published: (2024-11-01)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
by: Juntao Yin, et al.
Published: (2023-01-01)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
by: Yi-Xing Yang, et al.
Published: (2020-01-01)

Drug-Eluting Stents and Balloons—Materials, Structure Designs, and Coating Techniques: A Review
by: I. Rykowska, et al.
Published: (2020-10-01)

Drug Release Analysis and Optimization for Drug-Eluting Stents
by: Hongxia Li, et al.
Published: (2013-01-01)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
by: Michał Hawranek, et al.
Published: (2021-12-01)

Modeling and Analysis of Drug-Eluting Stents With Biodegradable PLGA Coating: Consequences on Intravascular Drug Delivery
by: Zhu, Xiaoxiang, et al.
Published: (2017)

Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
by: Masaki Hirose, et al.
Published: (2023-01-01)

Second Generation Drug-Eluting Stents: A Review of the Everolimus-Eluting Platform
by: Matthew G. Whitbeck, et al.
Published: (2013-01-01)

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
by: Ahmed Abdelaziz, et al.
Published: (2024-11-01)

Chiral Separation of Apremilast by Capillary Electrophoresis Using Succinyl-β-Cyclodextrin—Reversal of Enantiomer Elution Order by Cationic Capillary Coating
by: Zoltán-István Szabó, et al.
Published: (2023-04-01)

Drug-Coated Balloons versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis: A Pair-Wise Meta-Analysis of Randomized Trials
by: Nina Peng, et al.
Published: (2020-01-01)

Studies of biodegradable drug-eluting tracheal stents
by: Ng, Anthony Herr Cheun
Published: (2012)

Drug-Eluting Stents: Technical and Clinical Progress
by: Maciej Koźlik, et al.
Published: (2023-02-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V®)
by: Imad Sheiban, et al.
Published: (2008-02-01)

Overview of intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent
by: Sohila Refahi, et al.
Published: (2019-03-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
by: Xiao-Fang Tang, et al.
Published: (2018-08-01)

Mathematical modeling and simulation of intravascular drug delivery from drug-eluting stents with biodegradable PLGA coating
by: Zhu, Xiaoxiang, Ph. D. Massachusetts Institute of Technology
Published: (2015)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
by: Jonathan Hanna, et al.
Published: (2023-04-01)

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
by: Cheng-Hsuan Tsai, et al.
Published: (2022-06-01)

Stent Fracture after Everolimus-Eluting Stent Implantation
by: Ali S. Almasood, et al.
Published: (2011-01-01)

A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
by: Yinping Zhao, et al.
Published: (2021-02-01)

Drug‐Coated Balloons Versus Drug‐Eluting Stents or Plain Old Balloon Angioplasty: A Long‐Term in‐Stent Restenosis Study
by: Sacharias von Koch, et al.
Published: (2024-12-01)

Novel drug-eluting stent to reduce fibrosis-induced ureteral stricture
by: Fong, Timothy Ren Zhong
Published: (2015)

Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
by: Spadaccio Cristiano, et al.
Published: (2016-01-01)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023-05-01)

Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
by: Porto, I, et al.
Published: (2005)

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
by: Yi-Xing Yang, et al.
Published: (2023-01-01)

A Case Summary of the Application of a Drug-Eluting Stent Combined with a Drug-Coated Balloon in Left Main Coronary Artery Disease
by: Rong-Xue Xiao, et al.
Published: (2022-04-01)